The history of blue pus

Journal of the American College of Surgeons

Volumn 187, Issue 2, 1998, Pages 212-216

  Villavicencio, Raphael T ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; UREIDOPENICILLIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; HOSPITAL INFECTION; INTENSIVE CARE UNIT; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PUS; REVIEW;

ANIMALS; BACTERIOLOGY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 0031828361     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00137-9     Document Type: Review

References (39)

1. Pinner RW, Teutsch SM, Simonsen L, et al. Trends in infectious diseases mortality in the United States. JAMA 1996;275:189-193.
2. Emori TG and Gaynes RP. Ail overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-442.
3. Morrison AJ and Wenzel RP. Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 1984;6(suppl 3):S627-S642.
4. Jarvis WR and Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;29(suppl A):19-24.
5. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995;274: 639-644.
6. Rockefeller University Workshop. Multiple-antibiotic-resistant pathogenic bacteria. N Engl J Med 1994;330:1247-1251.
7. Bennett JV. Nosocomial infections due to pseudomonas. J Infect Dis 1974;130:S4-S7.
8. Gessard C. Thèse pour le doctorate en medecine: De la pyocyanine et de son microbe. Paris: July 20, 1882.
9. Kline BS and Maschke AS. Three fatal cases of Bacillus pyocyaneus infection. JAMA 1932;98:528-532.
10. Gerster AG. The Rules of Aseptic and Antiseptic Surgery. New York, NY: D. Appleton and Company; 1888.
11. Senn N. Surgical Bacteriology. Philadelphia, PA: Lea Brothers and Company; 1889.
12. Burnett CH, Conner PS, Dennis FS, et al. Surgical Bacteriology. In: Keen WW, White JW, eds. An American Textbook of Surgery for Practitioners and Students. Philadelphia, PA: WB Saunders; 1893:1-10.
13. Robb H. Aseptic Surgical Technique. Philadelphia: JB Lippincott Company; 1894.
14. Barker LF. The clinical symptoms, bacteriologic findings, and postmortem appearance in cases of infection of human beings with the Bacillus pyocyaneus. JAMA 1897;29:213-216.
15. Freeman L. Chronic general infection with the Bacillus pyocyaneus. Ann Surg 1916;64:195-202.
16. Elrod RP and Braun AC. A phytopathogenic bacterium fatal to laboratory animals. Science 1941;94:520-521.
17. Kerby GP. Pseudomonas aeruginosa bacteremia. Am J Dis Child 1947;74:610-615.
18. Haynes WC. Pseudomonas aeruginosa - its characterization and identification. J Gen Microbiol 1951;5:939-950.
19. Markley K, Gurmendi G, Chavez PM, and Bazan A. Fatal pseudomonas septicemias in burned patients. Ann Surg. 1957;145:175-181.
20. Tumbusch WT, Vogel EH, Butkiewicz JV, et al. Septicemia in burn injury. J Trauma 1961;1:22-31.
21. Luterman A, Dacso CC, and Curreri PW. Infections in burn patients. Am J Med 1986;81:45-50.
22. Stone HH, and Kolb LD. The evolution and spread of gentamicin-resistant pseudomonads. J Trauma 1971;11:586-589.
23. Matsumoto T, Wyle SR, Moseley RV, et al. Combat surgery in communication zone: war wound and bacteriology. Mil Med 1969;134:655-665.
24. Stillwell M and Caplan ES. The septic multiple trauma patient. Infect Dis Clin North Am 1989;3:155-183.
25. Pruitt Jr BA. Infections caused by pseudomonas species in patients with burns and in other surgical patients. J Infect Dis 1974; 130(supplement) :S8-S13.
26. Mcmanus AT, Mason Jr AD, Mcmanus WF, and Pruitt BA. Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center. Eur J Clin Microbiol 1985;4:219-233.
27. McManus AT, Moody EE, and Mason AD. Bacterial motility: a component in experimental Pseudomonas aeruginosa burn wound sepsis. Burns 1980;6:235-239.
28. Liu PV, Abe Y, and Bates JL. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. J Infect Dis 1961; 108:218-228.
29. Liu PV Factors that influence toxigenicity of Pseudomonas aeruginosa. J Bacteriol 1964;88:1421-1427.
30. Liu PV The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis: effects of lecithinase and protease. J Infect Dis 1966;116:112-116.
31. Liu PV The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis: identity of the lethal toxins produced in vitro and in vivo. J Infect Dis 1966;116:481-489.
32. Cross AS. Pseudomonas aeruginosa. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and Practice of Infectious Diseases. New York, NY: John Wiley and Sons; 1979:1705-1720.
33. Agger WA and Mardan A. Pseudomonas aeruginosa infections of intact skin. Clin Infect Dis 1995;20:302-308.
34. Service RF. Antibiotics that resist resistance. Science 1995;270: 724-727.
35. Chopra I, Hodgson J, Metcalf B, and Poste G. The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics. Antimicrob Agents Chemother 1997;41:497-503.
36. Jones RN, Kehrberg EN, Erwin ME, et al. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. Diagn Microbiol Infect Dis 1994;19:203-215.
37. Prins JM, van Deventer SJH, Kuijper EJ, and Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994;38:1211-1218.
38. Morrell V. Antibiotic resistance: road of no return. Science 1997; 278:575-576.
39. Salyers AA and Amabile-Cuevas CF. Why are antibiotic resistance genes so resistant to elimination? Antimicrob Agents Chemother 1997;41:2321-2325.